Cargando…
Interleukin-28B polymorphisms and hepatitis C virus clearance
In 2009, several independent studies revealed a strong association between genetic variation in the interleukin-28B (IL28B) locus and the outcome of treatment for chronic infection with hepatitis C virus (HCV). Hundreds of studies followed, and a recent meta-analysis reports more precise odds ratios...
Autores principales: | Chayama, Kazuaki, Hayes, C Nelson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738156/ https://www.ncbi.nlm.nih.gov/pubmed/24533893 http://dx.doi.org/10.1186/gm410 |
Ejemplares similares
-
Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
por: Jiménez-Sousa, María A, et al.
Publicado: (2013) -
Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance
por: di Iulio, Julia, et al.
Publicado: (2011) -
Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection
por: Kim, Seung Up, et al.
Publicado: (2013) -
Genetic Variation in the Interleukin-28B Gene Is Associated with Spontaneous Clearance and Progression of Hepatitis C Virus in Moroccan Patients
por: Ezzikouri, Sayeh, et al.
Publicado: (2013) -
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines
por: Chayama, Kazuaki, et al.
Publicado: (2012)